EHWM
CTAS icon

Eads & Heald Wealth Management’s Cintas CTAS Stock Holding History

Eads & Heald Wealth Management’s Portfolio CTAS Stock Details CTAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.4M Buy
8,249
+5
+0.1% +$959 0.7% 58
2025
Q4 		$1.55M Sell
8,244
-183
-2% -$34.5K 0.75% 60
2025
Q3 		$1.73M Sell
8,427
-256
-3% -$54.7K 0.83% 54
2025
Q2 		$1.94M Sell
8,683
-512
-6% -$110K 0.96% 40
2025
Q1 		$1.89M Sell
9,195
-88
-0.9% -$17.5K 0.96% 45
2024
Q4 		$1.7M Sell
9,283
-371
-4% -$78K 0.83% 50
2024
Q3 		$1.99M Sell
9,654
-1,186
-11% -$229K 0.94% 43
2024
Q2 		$1.9M Sell
10,840
-784
-7% -$134K 0.92% 49
2024
Q1 		$2M Sell
11,624
-1,208
-9% -$186K 0.93% 45
2023
Q4 		$1.93M Sell
12,832
-396
-3% -$53.1K 0.93% 42
2023
Q3 		$1.59M Sell
13,228
-828
-6% -$103K 0.83% 52
2023
Q2 		$1.75M Buy
14,056
+832
+6% +$97.6K 0.86% 52
2023
Q1 		$1.53M Sell
13,224
-588
-4% -$64.8K 0.76% 65
2022
Q4 		$1.56M Buy
13,812
+4
+0% +$433 0.79% 57
2022
Q3 		$1.34M Buy
13,808
+1,784
+15% +$182K 0.76% 59
2022
Q2 		$1.12M Buy
12,024
+572
+5% +$55.7K 0.6% 76
2022
Q1 		$1.22M Buy
11,452
+556
+5% +$54.1K 0.56% 80
2021
Q4 		$1.21M Buy
10,896
+240
+2% +$25.9K 0.52% 85
2021
Q3 		$1.01M Buy
10,656
+1,096
+11% +$107K 0.49% 89
2021
Q2 		$913K Buy
9,560
+2,324
+32% +$206K 0.45% 96
2021
Q1 		$617K Sell
7,236
-100
-1% -$8.46K 0.32% 102
2020
Q4 		$648K Sell
7,336
-84
-1% -$7.29K 0.35% 98
2020
Q3 		$617K Sell
7,420
-1,144
-13% -$88.2K 0.37% 95
2020
Q2 		$570K Sell
8,564
-416
-5% -$24.1K 0.35% 96
2020
Q1 		$389K Sell
8,980
-20
-0.2% -$1.31K 0.27% 104
2019
Q4 		$605K Buy
9,000
+8
+0.1% +$526 0.32% 103
2019
Q3 		$603K Buy
8,992
+156
+2% +$9.99K 0.34% 102
2019
Q2 		$524K Buy
8,836
+60
+0.7% +$3.32K 0.3% 106
2019
Q1 		$443K Buy
8,776
+1,536
+21% +$74.4K 0.26% 109
2018
Q4 		$304K Buy
7,240
+1,220
+20% +$54.5K 0.2% 112
2018
Q3 		$298K Buy
+6,020
New +$311K 0.17% 114

Other funds holding CTAS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Eads & Heald Wealth Management's CTAS Position: Q1 2026 in Review

Eads & Heald Wealth Management increased its Cintas (CTAS) stake by 0.06% in Q1 2026, buying an estimated $959 and bringing the position to 8,249 shares worth $1.4M. The position accounts for 0.7% of the portfolio, ranked #58.

Eads & Heald Wealth Management first reported a position in CTAS in Q3 2018 and has held it in 31 quarters since. The position peaked at $2M in Q1 2024. 1,429 funds tracked by Wall St. Rank hold CTAS as of Q1 2026.

  • Eads & Heald Wealth Management held 8,249 shares of Cintas worth $1.4M as of Q1 2026.
  • Eads & Heald Wealth Management bought 5 Cintas shares in Q1 2026, an estimated $959.
  • Cintas made up 0.7% of Eads & Heald Wealth Management's portfolio in Q1 2026, its #58 holding.
  • Eads & Heald Wealth Management first reported a position in Cintas in Q3 2018 and has held it in 31 quarters since.
  • Eads & Heald Wealth Management's Cintas position peaked at $2M in Q1 2024.
  • 1,429 funds tracked by Wall St. Rank held Cintas as of Q1 2026.

Based on Eads & Heald Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.